Manage Your Liver
Q:

I am infected with HCV, if I do not undergo antiviral treatment (due to the cost and side effects), is it possible for me to maintain normal liver function?

A:

Sometimes, people infected with HCV choose not to or cannot undergo treatment to eradicate the virus because of a number of reasons (e.g. price of treatment, side effects, condition of the liver, overall health condition, recurring infection, etc.) [1] When not using antiviral treatment, patients should aim at protecting their liver cells from damage and preserving liver function. [2]

 

For hepatitis C patients, maintaining normal liver function can greatly reduce the risk of cirrhosis and liver cancer. The liver can regenerate most of its own cells when they become damaged. However, if the injury is severe or long lasting, regeneration is incomplete, and the liver creates scar tissue. Scarring of the liver or fibrosis, may lead to cirrhosis. [3] And cirrhosis is the main cause for primary liver cancer. [4]

 

People infected with hepatitis virus may find it more difficult to maintain normal liver function than those who do not have the virus. However, there is little correlation between the severity of liver damage and HCV viral load. A high viral load does not indicate serious liver damage, similarly, a low viral count does not equal little liver injury. [5] Hence, maintaining normal liver function is possible even without eradication of the virus. In fact, this has already been proven in scientific research. [6]

 

People with HCV infection who are unable to undergo virus eradication treatment should focus on adopting lifestyle changes to reduce workload on the liver, avoiding harmful substances to the liver and enhancing immune function to fend off liver damage from the virus.

 

For more tips please read: How can I reduce workload on the liver and increase immune function of the liver?

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Hepatitis CHCVHep CAntiviral Treatment
Related Questions
A:
In our last post, we brought up the recent findings on extreme liver cancer growth after successful DAA treatment. We are talking about liver cancer of a few centimetres developed within weeks of successful Hep C treatment. These findings are also observed in patients of Gastroenterology. Dr. Roushdi Khalf allah sai
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us